FSHD Connect is the FSHD Society's flagship educational conference. Held every two years, it is the world's biggest networking event for FSHD, bringing together hundreds of individuals and families living with FSH muscular dystrophy, clinicians, and researchers for two days of immersive learning and workshops. You'll find out about the latest research, drug development, and clinical trials, as well as a wealth of news you can use, from managing symptoms to navigating the challenges of daily life. You'll be meeting and learning from the greatest experts—other patients and families like yours! Mark your calendars. We have reserved a block of rooms at the conference hotel and you'll hear more about it in early 2022. We can't wait to see you!
Check out the talks from our last FSHD Connect in 2020!
2020 FSHD Connect Classroom - Nothing will stop usThe 2020 FSHD Connect Classroom is the FSHD Society's virtual meeting which takes the place of the biennial FSHD Connect conference. It is the world's premier gathering for individuals and families living with facioscapulohumeral muscular dystrophy, researchers, clinicians, and advocates. COVID-19 will not slow us down. Together, we will prevail. For more information, visit www.fshdsociety.org
FSHD 101 - What causes FSHD? With Matt Harms, MDFrom the 2020 FSHD Connect Classroom conference. Dr. Matthew Harms of Columbia University Medical Center provides a lucid explanation of the genetic mechanism underlying FSH muscular dystrophy. For more information, visit www.fshdsociety.org.
FSHD 101 Managing the Condition, with Nicholas Johnson, MDFrom the 2020 FSHD Connect Classroom conference. Dr. Nicholas Johnson of the Virginia Commonwealth University's FSHD research center, reviews the symptoms and treatments for FSH muscular dystrophy. For more information, visit www.fshdsociety.org.
The 2020 FSHD Connect Classroom was held on Saturday, June 27, 2020, as a one-day online conference, to take the place of our biennial FSHD Connect conference. The conference was a great success, with more than 400 registrants who enjoyed a series of stellar presentations by medical and research superstars, with the latest news on medical care, drug development, and our nationwide initiatives. We will be posting videos and slides from the conference shortly. (To browse previous FSHD Connect conferences, scroll down.)
Slides and additional resources on orthotics from Allard can be downloaded here. Use pass: Webinar2020
2018 FSHD Connect Videos!
Our 2018 FSHD Connect conference was held at the Flamingo Las Vegas on June 9-10, 2018. The conference gathered together 400 patients, family members, researchers, physicians, and health experts for a day-and-a-half of intensive learning and community activism. Our meeting featured talks by thought leaders on the latest in scientific research and medical management of FSHD, including 10 academic and industry researchers who are actively working on new treatments for FSHD. The FSH Society also launched its national chapter program at this meeting.
Please share this post with family members and urge them to join the FSH Society if they have not done so already. There has never been a more important time for all individuals with FSHD and their families to be actively engaged with these efforts.
2016 FSHD Patient Connect Conference
The FSH Society’s 2016 Patient Connect conference was held on Friday, November 11, (noon to 5:00PM) and Saturday, November 12, 2016 (9:00-5:00 PM) at the Westin Copley Place Hotel in Boston, Massachusetts. The conference brought together hundreds of patients and family members with top researchers, doctors and health experts for two days of immersive learning and community-building. Download the Patient Connect program here.
Presentations and breakout sessions slides can be downloaded by clicking on the highlighted titles* to the right.
*If a talk is not highlighted, the slides are not yet available.
- FSHD Science 101. Alexandra Belayew, PhD (VIDEO)
- Genetics and genetic testing. Silvere van der Maarel, PhD (VIDEO)
- How FSHD affects your body and health. Kathryn Wagner, MD (VIDEO)
- Getting to know you. Claudio Ordonez, MD (VIDEO)
- Treatment strategies (panel): Peter Jones, PhD; Yi-Wen Chen, PhD; Scott Harper, PhD (VIDEO)
- Getting ready for clinical trials. Jeff Statland, MD (VIDEO)
- Clinical trials: current and impending. Rabi Tawil, MD (VIDEO)
- FSHD tissue donation registry. Denee Tidwell (VIDEO)
- Physical Therapy & Exercise (Katy Eichinger, PhD)
- Respiratory health (Nicholas Hill, MD)
- Living well: Life with FSHD (Ora Prilleltensky, EdD)
- Loving well: Living with a person with FSHD (Isaac Prilleltensky, PhD)
- Pregnancy & women’s health (Kelly Minks, MS, CGC)
- Waking up your muscles (Lynnette Rasmussen)
- Managing pain & chronic fatigue (Katy Eichinger, PhD)
- For the newly diagnosed & mildly affected (Carol Birnbaum, MD)
- Living well and loving well: Meeting everyone’s needs (Ora Prilleltensky, EdD & Isaac Prilleltensky, PhD)
2014 FSHD Connect Conference
Event Date: Saturday-Sunday, August 16-17, 2014
Event Place: The Westin Boston Waterfront
425 Summer Street
Boston MA 02210
The 2014 FSHD Connect Meeting, sponsored by the FSH Society, brought together hundreds of patients and family members with top researchers, doctors and health experts for two days of immersive learning and community-building. This year’s meeting featured talks by leaders in the field of FSHD, including reports from major clinical and research centers, question-and-answer panel sessions, and educational workshops. Popular breakout sessions include topics that members requested, including teenagers and young adults, caregiving, traveling and sports. View the 2014 FSHD Connect Final Program here.
Here are the slide decks from the 2014 FSHD Connect conference:
- Peter Jones: Genetically similar, epigenetically different
- Ray Huml: Natural history studies
- Sabrina Sacconi: FSHD & Nutrition
- Shree Pandya: Update on physical therapy and exercise recommendations
- Stephen Tapscott: Consensus model for FSHD identifies opportunities for therapy
- Yi-Wen Chen: Multicenter infantile onset FSHD study